Sinopharm
1099.HK
#2261
Rank
โ‚น786.92 B
Marketcap
โ‚น252.17
Share price
-0.09%
Change (1 day)
17.98%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2024: โ‚น7.283 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.283 Trillion. In 2024 the company made a revenue of โ‚น7.283 Trillion a decrease over the revenue in the year 2023 that were of โ‚น7.675 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2024

Annual revenue

Year Revenue Change
2024โ‚น7.283 T-5.1%
2023โ‚น7.675 T5.42%
2022โ‚น7.280 T-2.1%
2021โ‚น7.436 T16.85%
2020โ‚น6.364 T14.95%
2019โ‚น5.536 T21.52%
2018โ‚น4.556 T5.93%
2017โ‚น4.301 T27.22%
2016โ‚น3.380 T5.37%
2015โ‚น3.208 T9.14%
2014โ‚น2.939 T17.22%
2013โ‚น2.507 T25.94%
2012โ‚น1.991 T34.61%
2011โ‚น1.479 T55.34%
2010โ‚น952.24 B35.79%
2009โ‚น701.26 B37.56%
2008โ‚น509.80 B31.43%
2007โ‚น387.89 B40.26%
2006โ‚น276.55 B